Retraction Note: Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway

Cancer Cell Int. 2024 Sep 18;24(1):320. doi: 10.1186/s12935-024-03508-w.

Xuejiao Liu^{1

2}, Yiming Tu^{1

3}, Yifeng Wang¹, Di Zhou¹, Yulong Chong⁴, Lin Shi¹, Guanzheng Liu¹, Xu Zhang^{1

2}, Sijin Wu⁵, Huan Li¹, Shangfeng Gao^{1

2}, Mingshan Niu^{1

6}, Rutong Yu^{7

8}

¹ Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China.
² Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.
³ Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
⁴ Department of Neurosurgery, Suqian Hospital Affiliated to Xuzhou Medical University, Suqian, Jiangsu, China.
⁵ College of Pharmacy, The Ohio State University, Columbus, OH, USA.
⁶ Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China.
⁷ Insititute of Nervous System Diseases, Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China. [email protected].
⁸ Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China. [email protected].

No abstract available

Publication types